The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic
Open accessAbstract
IMPORTANCE: Wild-type (WT) gastrointestinal stromal tumors (GISTs), which lack KIT and PDGFRA gene mutations, are the primary form of GIST in children and occasionally occur in adults. They respond poorly to standard targeted therapy. Better molecular and clinical characterization could improve management. OBJECTIVE: To evaluate the clinical and tumor genomic features of WT GIST. DESIGN, SETTING, AND PARTICIPANTS: Patients enrolled in an observational study at the National Institutes of Health starting in 2008 and were evaluated in a GIST clinic held once or twice yearly. Patients provided access to existing medical records and tumor specimens. Self-referred or physician-referred patients younger than 19 years with GIST or 19 years or older with known WT GIST (no mutations in KIT or PDGFRA) were recruited; 116 patients with WT GIST were enrolled, and 95 had adequate tumor specimen available. Tumors were characterized by immunohistochemical analysis (IHC) for succinate dehydrogenase (SDH) subunit B, sequencing of SDH genes, and determination of SDHC promoter methylation. Testing of germline SDH genes was offered to consenting patients and families. MAIN OUTCOMES AND MEASURES: For classification, tumors were characterized by SDHA, B, C, or D (SDHX) mutations and other genetic and epigenetic alterations, including presence of mutations in germline. Clinical characteristics were categorized. RESULTS: Wild-type GIST specimens from 95 patients (median age, 23 [range, 7-78] years; 70% female) were classified into 3 molecular subtypes: SDH-competent (n = 11), defined by detection of SDHB by IHC; and 2 types of SDH-deficient GIST (n = 84). Of SDH-deficient tumors, 63 (67%) had SDH mutations, and in 31 of 38 (82%), the SDHX mutation was also present in germline. Twenty-one (22%) SDH-deficient tumors had methylation of the SDHC promoter leading to silencing of expression. Mutations in known cancer-associated pathways were identified in 9 of 11 SDH-competent tumors. Among patients with SDH-mutant tumors, 62% were female (39 of 63), median (range) age was 23 (7-58) years, and approximately 30% presented with metastases (liver [12 of 58], peritoneal [6 of 58], lymph node [15 of 23]). SDHC-epimutant tumors mostly affected young females (20 of 21; median [range] age, 15 [8-50] years), and approximately 40% presented with metastases (liver [7 of 19], peritoneal [1 of 19], lymph node [3 of 8]). SDH-deficient tumors occurred only in the stomach and had an indolent course. CONCLUSIONS AND RELEVANCE: An observational study of WT GIST permitted the evaluation of a large number of patients with this rare disease. Three molecular subtypes with implications for prognosis and clinical management were identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
Hirota, S., Isozaki, K., Moriyama, Y., Hashimoto, K., Nishida, T., Ishiguro, S., Kawano, K., Hanada, M., Kurata, A., Takeda, M., et al. (1998) · Science · doi:10.1126/science.279.5350.577 · Cited by 4,490
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 1×
“15 [8-50] years), and approximately 40% presented with metastases (liver [7 of 19],”
BackgroundNilsson, B., Bümming, P., Meis‐Kindblom, J. M., Odén, A., Dortok, A., Gustavsson, B., Sablinska, K., & Kindblom, L. (2005) · Cancer · doi:10.1002/cncr.20862 · Cited by 1,272
Biology of Gastrointestinal Stromal Tumors
Corless, C. L., Fletcher, J. A., & Heinrich, M. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.140 · Cited by 1,224
Heinrich, M. C., Owzar, K., Corless, C. L., Hollis, D., Borden, E. C., Fletcher, C. D. M., Ryan, C. W., von Mehren, M., Blanke, C. D., Rankin, C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.4284 · Cited by 641
Self-citationToro, J. R., Nickerson, M. L., Wei, M.-H., Warren, M. B., Glenn, G. M., Turner, M. L., Stewart, L., Duray, P., Tourre, O., Sharma, N., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/376435 · Cited by 634
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
Self-citationPasini, B., McWhinney, S. R., Bei, T., Matyakhina, L., Stergiopoulos, S., Muchow, M., Boikos, S. A., Ferrando, B., Pacak, K., Assie, G., et al. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201904 · Cited by 487
Self-citationNovel V600E BRAF mutations in imatinib‐naive and imatinib‐resistant gastrointestinal stromal tumors
Agaram, N. P., Wong, G. C., Guo, T., Maki, R. G., Singer, S., DeMatteo, R. P., Besmer, P., & Antonescu, C. R. (2008) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20589 · Cited by 388
Tryggvason, G., Gíslason, H. G., Magnússon, M. K., & Jónasson, J. G. (2005) · International Journal of Cancer · doi:10.1002/ijc.21167 · Cited by 358
Killian, J. K., Kim, S. Y., Miettinen, M., Smith, C., Merino, M., Tsokos, M., Quezado, M., Smith, W. I., Jahromi, M. S., Xekouki, P., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0092 · Cited by 356
Self-citationIDH1 and IDH2 Mutations in Gliomas
Uhm, J. (2009) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(09)79085-4 · Cited by 322
BRAF Mutation Status in Gastrointestinal Stromal Tumors
Hostein, I., Faur, N., Primois, C., Boury, F., Denard, J., Emile, J.-F., Bringuier, P.-P., Scoazec, J.-Y., & Coindre, J.-M. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcppckga2qgbj1r · Cited by 232
Recurrent epimutation of SDHC in gastrointestinal stromal tumors
Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009961 · Cited by 193
Self-citationARID1A gene mutation in ovarian and endometrial cancers (Review)
TAKEDA, T., BANNO, K., OKAWA, R., YANOKURA, M., IIJIMA, M., IRIE-KUNITOMI, H., NAKAMURA, K., IIDA, M., ADACHI, M., UMENE, K., et al. (2016) · Oncology Reports · doi:10.3892/or.2015.4421 · Cited by 187
Perez, E. A., Livingstone, A. S., Franceschi, D., Rocha-Lima, C., Lee, D. J., Hodgson, N., Jorda, M., & Koniaris, L. G. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2006.01.002 · Cited by 185
Falchook, G. S., Trent, J. C., Heinrich, M. C., Beadling, C., Patterson, J., Bastida, C. C., Blackman, S. C., & Kurzrock, R. (2013) · Oncotarget · doi:10.18632/oncotarget.864 · Cited by 169
Self-citationSunitinib treatment in pediatric patients with advanced GIST following failure of imatinib
Janeway, K. A., Albritton, K. H., Van Den Abbeele, A. D., D'Amato, G. Z., Pedrazzoli, P., Siena, S., Picus, J., Butrynski, J. E., Schlemmer, M., Heinrich, M. C., et al. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21909 · Cited by 162
Self-citationInhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells
Cervera, A. M., Bayley, J.-P., Devilee, P., & McCreath, K. J. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-89 · Cited by 156 · cited 1×
“15 [8-50] years), and approximately 40% presented with metastases (liver [7 of 19],”
BackgroundMatyakhina, L., Bei, T. A., McWhinney, S. R., Pasini, B., Cameron, S., Gunawan, B., Stergiopoulos, S. G., Boikos, S. A., Muchow, M., Dutra, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0797 · Cited by 152
Self-citationPediatric Gastrointestinal Stromal Tumors
Pappo, A. S., & Janeway, K. A. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2008.11.005 · Cited by 152
Self-citationCarney, J. A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1156 · Cited by 116
Evenepoel, L., Papathomas, T. G., Krol, N. M. G., Korpershoek, E., de Krijger, R. R., Persu, A., & Dinjens, W. N. M. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.162 · Cited by 115
Targeting ABL1-Mediated Oxidative Stress Adaptation in Fumarate Hydratase-Deficient Cancer
Sourbier, C., Ricketts, C. J., Matsumoto, S., Crooks, D. R., Liao, P., Mannes, P. Z., Yang, Y., Wei, M.-H., Srivastava, G. K., Ghosh, S., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.005 · Cited by 115
Pantaleo, M. A., Nannini, M., Corless, C. L., & Heinrich, M. C. (2014) · Cancer Medicine · doi:10.1002/cam4.325 · Cited by 101
Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families
Jasperson, K. W., Kohlmann, W. K., Gammon, A., Slack, H., Buchmann, L. O., Hunt, J. P., Kirchhoff, A. C., Baskin, H., Shaaban, A. M., & Schiffman, J. D. (2013) · Familial Cancer · doi:10.1007/s10689-013-9639-6 · Cited by 91
Self-citationSuccinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors
Belinsky, M. G., Rink, L., & von Mehren, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00117 · Cited by 66
Pediatric gastrointestinal stromal tumor
Janeway, K. A., & Weldon, C. B. (2012) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2011.10.003 · Cited by 53
Self-citationJaneway, K., Kim, S., Lodish, M., Nose, V, Rustin, P., Gaal, J., Dahia, P., Liegl, B., Ball, E., Raygada, M., et al. (2011) · EUR Research Repository (Erasmus University Rotterdam) · Cited by 46
Self-citationZou, Y., Zeng, Y., Zhang, D., Zou, S., Cheng, Y., & Yao, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.038 · Cited by 45
Widemann, B. C., Marcus, L. J., Fisher, M. J., Weiss, B., Kim, A., Dombi, E., Baldwin, A. M., Whitcomb, P. O., Martin, S. C., Gillespie, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.10018 · Cited by 39
The role of mutation of metabolism-related genes in genomic hypermethylation
Waterfall, J. J., Killian, J. K., & Meltzer, P. S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.003 · Cited by 24
Self-citation
Cited by
Gastrointestinal stromal tumours
Blay, J.-Y., Kang, Y.-K., Nishida, T., & von Mehren, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00254-5 · Cited by 460
Self-citationNew Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification
Crona, J., Taïeb, D., & Pacak, K. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00062 · Cited by 324
Self-citationGastrointestinal Stromal Tumors
von Mehren, M., & Joensuu, H. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9705 · Cited by 306
Self-citationMitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295
“SDHA-D GIST Abdominal pain, gastrointestinal bleeding [91,100]”
Ripperger, T., Bielack, S. S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K., Deubzer, H., Dirksen, U., Eckert, C., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38142 · Cited by 283
Metadata
- Authors
- Boikos, S. A., Pappo, A. S., Killian, J. K., LaQuaglia, M. P., Weldon, C. B., George, S., Trent, J. C., von Mehren, M., Wright, J. A., Schiffman, J. D., Raygada, M., Pacak, K., Meltzer, P. S., Miettinen, M. M., Stratakis, C., Janeway, K. A., & Helman, L. J.
- Venue
- JAMA Oncology
- Publisher
- American Medical Association (AMA)
- Published
- 2016-07-01
- Volume
- 2
- Issue
- 7
- Pages
- 922
- ISSN
- 2374-2437 (ISSN-L)
- OpenAlex
- W2308064764
- Cited by
- 416
- References
- 34
- FWCI
- 36.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.